A Randomised Multicentre Open Label Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 3 Chronic Kidney Disease

Project Details

StatusFinished
Effective start/end date1/03/1428/02/18

Funding

  • Other: £168,171.00